HALO
SELLHalozyme Therapeutics, Inc.· Healthcare
Market Cap: $14.2B
Score
20
20
ANDAMENTO PREZZO
$124.83+89.51%
Prezzi aggiornati al 21 ott 2026
INDICATORI TECNICI
RSI (14 giorni)
▪ <30 Ipervenduto (segnale buy)
▪ 30–45 Zona debolezza
▪ 45–55 Neutro
▪ >70 Ipercomprato (attenzione)
MACD (12,26,9)
↑ RialzistaMACD 4.064 · Signal 2.822 · Hist 1.242
Prezzo vs Medie Mobili
SMA 20
$114.12-47.0%
SMA 50
$110.18-45.2%
SMA 200
$81.43-25.8%
Bollinger Band %B0% — Vicino lower band
$103mid $114$126
Volume ratio (vs media 20gg)0.74x
BREAKDOWN SCORE (0 → 100)
P/E Trailing0.0 / 25
FCF Yield10.3 / 25
Price/Book0.0 / 15
EPS5.1 / 15
Debt/Equity0.0 / 10
Dividendo0.0 / 5
Momentum 90gg5.0 / 5
FONDAMENTALI
Clicca i per spiegazione✓ 3 ok~ attenzione✗ 3 negativi
✗P/E Trailing
36.5x
✓P/E Forward
11.7x
✗P/B
99.2x
~FCF Yield
2.5%
✓EPS TTM
3,42
EPS Q1
—
EPS Growth YoY
—
✓Rev. Growth
47.7%
✗Debt/Equity
15.2x
Market Cap
$14.2B
Div. Yield
0.0%
Beta
—
52w High
—
52w Low
—
DCF Value
—
Sector
Healthcare
Aggiornato: 22 ott 2026